NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $214,000 | +3.9% | 2,526 | +0.1% | 0.02% | +18.8% |
| Q4 2021 | $206,000 | 0.0% | 2,524 | 0.0% | 0.02% | -15.8% |
| Q3 2021 | $206,000 | -13.8% | 2,524 | -3.8% | 0.02% | +5.6% |
| Q2 2021 | $239,000 | -14.6% | 2,624 | -20.0% | 0.02% | -25.0% |
| Q1 2021 | $280,000 | +18.1% | 3,278 | +30.3% | 0.02% | +9.1% |
| Q4 2020 | $237,000 | +16.2% | 2,515 | +7.1% | 0.02% | +4.8% |
| Q3 2020 | $204,000 | -5.1% | 2,349 | -4.6% | 0.02% | -12.5% |
| Q2 2020 | $215,000 | +0.5% | 2,463 | +8.9% | 0.02% | -7.7% |
| Q4 2019 | $214,000 | +3.9% | 2,261 | 0.0% | 0.03% | -10.3% |
| Q2 2019 | $206,000 | -22.6% | 2,261 | -18.4% | 0.03% | -23.7% |
| Q1 2019 | $266,000 | +11.8% | 2,770 | 0.0% | 0.04% | -2.6% |
| Q4 2018 | $238,000 | -21.5% | 2,770 | -21.2% | 0.04% | -9.3% |
| Q3 2018 | $303,000 | +29.5% | 3,514 | +13.4% | 0.04% | +19.4% |
| Q2 2018 | $234,000 | -22.8% | 3,098 | -17.3% | 0.04% | -23.4% |
| Q1 2018 | $303,000 | – | 3,746 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |